Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Kidney Transplantation

  Free Subscription


Articles published in Br J Clin Pharmacol

Retrieve available abstracts of 10 articles:
HTML format
Text format



Single Articles


    September 2017
  1. MAO JJ, Jiao Z, Yun HY, Zhao CY, et al
    External Evaluation of Population Pharmacokinetic Models for Cyclosporine in Adult Renal Transplant Recipients.
    Br J Clin Pharmacol. 2017 Sep 11. doi: 10.1111/bcp.13431.
    PubMed     Text format     Abstract available


  2. MILLAN O, Budde K, Sommerer C, Aliart I, et al
    Urinary miR-155-5p and CXCL10 as prognostic and predictive biomarkers of rejection, graft outcome and treatment response in kidney transplantation.
    Br J Clin Pharmacol. 2017 Sep 7. doi: 10.1111/bcp.13399.
    PubMed     Text format     Abstract available


    July 2017
  3. BREMER S, Vethe NT, Skauby M, Kasbo M, et al
    NFAT-regulated cytokine gene expression during tacrolimus therapy early after renal transplantation.
    Br J Clin Pharmacol. 2017 Jul 7. doi: 10.1111/bcp.13367.
    PubMed     Text format     Abstract available


    June 2017
  4. VANHOVE T, Hasan M, Annaert P, Oswald S, et al
    Pretransplant 4beta-hydroxycholesterol does not predict tacrolimus exposure or dose requirements during the first days after kidney transplantation.
    Br J Clin Pharmacol. 2017 Jun 11. doi: 10.1111/bcp.13343.
    PubMed     Text format     Abstract available


    April 2017
  5. KNOPS N, Herman J, van Dyck M, Ramazani Y, et al
    Tacrolimus dose requirements in paediatric renal allograft recipients are characterized by a biphasic course determined by age and bone maturation.
    Br J Clin Pharmacol. 2017;83:863-874.
    PubMed     Text format     Abstract available


    February 2017
  6. STORSET E, Hole K, Midtvedt K, Bergan S, et al
    THE CYP3A BIOMARKER 4beta-HYDROXYCHOLESTEROL DOES NOT IMPROVE TACROLIMUS DOSE PREDICTIONS EARLY AFTER KIDNEY TRANSPLANTATION.
    Br J Clin Pharmacol. 2017 Feb 1. doi: 10.1111/bcp.13248.
    PubMed     Text format     Abstract available


    October 2016
  7. TANG JT, de Winter BC, Hesselink DA, Sombogaard F, et al
    THE PHARMACOKINETICS AND PHARMACODYNAMICS OF MYCOPHENOLATE MOFETIL IN YOUNGER AND ELDERLY RENAL TRANSPLANT RECIPIENTS.
    Br J Clin Pharmacol. 2016 Oct 18. doi: 10.1111/bcp.13154.
    PubMed     Text format     Abstract available


    July 2016
  8. MOES DJ, Press RR, Ackaert O, Ploeger BA, et al
    Exploring genetic and non-genetic risk factors for delayed graft function, acute and subclinical rejection in renal transplant recipients.
    Br J Clin Pharmacol. 2016;82:227-37.
    PubMed     Text format     Abstract available


    December 2015
  9. SUZUKI Y, Fujioka T, Sato F, Matsumoto K, et al
    CYP3A5 polymorphism affects the increase in CYP3A activity after living kidney transplantation in patients with end stage renal disease.
    Br J Clin Pharmacol. 2015;80:1421-8.
    PubMed     Text format     Abstract available


    November 2015
  10. ZHAO CY, Jiao Z, Mao JJ, Qiu XY, et al
    External Evaluation of Published Population Pharmacokinetic Models of Tacrolimus in Adult Renal Transplant Recipients.
    Br J Clin Pharmacol. 2015 Nov 17. doi: 10.1111/bcp.12830.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Kidney Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: